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Abstract
Background: Tripeptidyl aminopeptidase I (TPPI) is a crucial lysosomal enzyme that is deficient in the fatal
neurodegenerative disorder called classic late-infantile neuronal ceroid lipofuscinosis (LINCL). It is involved in the
catabolism of proteins in the lysosomes. Recent X-ray crystallographic studies have provided insights into the structural/
functional aspects of TPPI catalysis, and indicated presence of an octahedrally coordinated Ca
2+.
Methodology: Purified precursor and mature TPPI were used to study inhibition by NBS and EDTA using biochemical and
immunological approaches. Site-directed mutagenesis with confocal imaging technique identified a critical W residue in
TPPI activity, and the processing of precursor into mature enzyme.
Principal Findings: NBS is a potent inhibitor of the purified TPPI. In mammalian TPPI, W542 is critical for tripeptidyl
peptidase activity as well as autocatalysis. Transfection studies have indicated that mutants of the TPPI that harbor residues
other than W at position 542 have delayed processing, and are retained in the ER rather than transported to lysosomes.
EDTA inhibits the autocatalytic processing of the precursor TPPI.
Conclusions/Significance: We propose that W542 and Ca
2+ are critical for maintaining the proper tertiary structure of the
precursor proprotein as well as the mature TPPI. Additionally, Ca
2+ is necessary for the autocatalytic processing of the
precursor protein into the mature TPPI. We have identified NBS as a potent TPPI inhibitor, which led in delineating a critical
role for W542 residue. Studies with such compounds will prove valuable in identifying the critical residues in the TPPI
catalysis and its structure-function analysis.
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Introduction
The mammalian tripeptidyl-peptidase I (TPPI, EC 3.4.14.9) is a
crucial endopeptidase involved in cleaving off tripeptides during
lysosomal protein catabolism [1–3]. The importance of functionally
active TPPI is evident from a debilitating neurodegenerative
disorder called the classic late-infantile neuronal ceroid lipofuscin-
osis (LINCL, OMIM 204500), also known as neuronal ceroid
lipofuscinosis 2 or Jansky-Bielschowsky disease [4,5]. LINCL is a
familial, fatal autosomal-recessive disorder afflicting children, which
is characterized by progressive retinal and neuronal degeneration
[6].LINCL,whose symptomsappear between 2 and 11 years of age
in affected individuals, is caused by mutations in the gene encoding
TPPI, denoted at TPP1. The resultant defective protein was first
identified throughaproteomicsapproach[7].Initiallyrecognizedas
a protein similar to bacterial carboxypeptidase, the gene product
was quickly identified as TPPI [8,9]. Histologically, the disorder is
characterized by the accumulation of characteristic curvilinear
autofluorescent storage bodies, ceroid lipofuscin, primarily in the
brain, but also in other tissues. The severity and the onset of clinical
symptoms of LINCL depend upon the type of mutation, some of
which cause the complete loss of functional activity, while others
result in altered proteins that retain partial peptidase activity. The
latter class of mutations results in a protracted phenotype with
delayed onset of symptoms and delayed mortality [10,11]. At
present, there are 68 different disease-causing mutations in the
TPP1 gene among different individuals listed in the NCL
mutational database (http://www.ucl.ac.uk/ncl/).
Currently, no efficacious treatment for LINCL is available;
treatment is mainly restricted to symptomatic relief. The course of
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genetic counseling is the only means for avoiding the occurrence of
LINCL, and several prenatal and carrier status testing assays are
available [12–17]. A number of promising therapeutic approaches
are also under investigation in the mouse models of LINCL [18–
20]. Structure-function studies of TPPI are necessary to identify
the molecular mechanisms associated with various mutations
occurring in LINCL to develop proper strategies for rational
therapeutic intervention. Expression of TPPI is augmented in
breast, esophageal and colorectal cancers suggesting its likely
involvement in cancer progression and metastasis [21–23]. In
metastasis, it is generally believed that due to the action of various
proteases, the basal lamina between epithelium and stroma
separates, resulting in detachment of metastatic cells. Increased
TPPI activity was also noticed in other neurological disorders
probably as a secondary consequence [24,25].
TPP1, is localized on chromosome 11p15, and the mRNA
transcribed encodes a ,69-kDa inactive zymogen precursor. The
precursor TPPI is glycosylated on four of the putative N-
glycosylation sites, with a final addition of a terminal mannose-
6-phosphorylation modification that assists in lysosomal sorting
[26–28]. After targeting into lysosomes, because of the acidic
environment, the TPPI is auto-catalytically processed into the
,48-kDa mature enzyme wherein it participates in protein
catabolism in conjunction with other proteases by facilitating the
removal of tripeptides [29]. It has been shown recently that the
prosegment of TPPI acts as an inhibitor as well as a molecular
chaperon of the mature enzyme, helping deliver the required
peptidase activity into the the lysosome [30]. In TPPI, the
glycosylation of N residues has been indispensable for the
biological function. The mutation N286S in an LINCL patient
was shown to cause the lack of a crucial glycosylation that
abrogated the peptidase activity [31]. In vitro site-directed
mutagenesis studies modifying the N286 residue have provided
conclusive evidence that glycosylation at this residue is critical for
the proper targeting of TPPI into the lysosome [27].
The crystal structures of both native and deglycosylated TPPI
were contrived recently, which has helped unravel the molecular
function of several mutations in the TPP1 gene [32,33]. TPPI is a
mammalian representative of the S53-type family of serine
proteases, and it is characterized by the presence of a bacterial
subtilisin-like fold, a catalytic triad comprising S475-E272-D360
residues and an octahedrally coordinated Ca
2+. Prokaryotic
examples of S53-type serine proteases include sedolisin, sedolisin
B, and kumamolisin [34]. Both the mammalian and prokaryotic
members of S53-type proteases share common features, such as
catalytic residues, pH optima, and substrate specificities. Chemical
modification studies along with site-directed mutagenesis have
provided unequivocal proof of the involvement of S475 in the
active site of TPP1. The sequence of active-site residues is
conserved in all members of the S53 family of proteases.
Substrate-specificity studies have shown that TPPI primarily
cleaves tripeptides from unsubstituted amino termini in peptides
and proteins. A substitution of the amino group on the P1 residue
in a peptide completely abolishes the TPPI activity. Studies with
combinatorial peptide libraries have indicated that substrates
containing a hydrophobic residue at P1 and a positively charged
residue at P3 were most favored [35]. In this aspect, TPPI appears
to be a general peptidase involved in protein catabolism in concert
with other lysosomal proteases. Apart from the primary tripepti-
dase activity, weaker endoproteolytic activity was also detected in
TPPI [36]. Although not proved conclusively, the presence of this
weaker endoproteolytic activity may be necessary for the
autocatalytic processing of the precursor into the mature enzyme.
Despite vigorous attempts by various groups, the natural substrates
for TPPI have not been identified. In vitro TPPI cleaves a number
of naturally occurring peptides such as mitochondrial ATP
synthase subunit c, angiotensin II, substance P, b-amyloid,
glucagons, and Bid, a Bcl2-interacting protein [36–38]. To date,
in LINCL, accumulation of only subunit c has been demonstrated
to be a component of autofluorescent ceroid lipofuscin [39]. While
in vitro studies have shown subunit c to be a substrate, its
accumulation has been reported in other neurological conditions;
therefore, subunit c accumulation does not solely results from a
lack of TPPI activity [40].
In out continuing efforts to delineate amino acid residues that
are critical in TPPI catalysis, we have found that N-bromosucci-
nimide (NBS) is a potent inhibitor of purified TPPI. In this report,
using biochemical and molecular biological approaches, we
present evidence that W residue at position 542 is critical for
TPPI activity. It is likely that NBS oxidized the indole group of this
residue, which molecular models show, forms tertiary interactions
with other residues in TPPI. Furthermore, we have shown that
Ca
2+ is essential for the autocatalytic processing of the precursor
zymogen to active TPPI, but is not necessary for the tripeptidyl
peptidase activity.
Results
TPPI activity is inhibited by in vitro incubation of NBS
Our initial studies were done with the apparently homogenous
bovine brain TPPI that was purified as described earlier [37]. The
purified TPPI was stored frozen at 220uC without any noticeable
loss in activity; furthermore, during extended periods of storage at
4uC, no proteolytic fragments were observed upon SDS-PAGE
separation followed by silver staining, indicating the lack of any
self-endoproteolytic activity in the purified TPPI fractions. The
purified TPPI is potently inhibited by freshly prepared NBS in a
concentration-dependent manner (Table 1) under the acidic
conditions of the assay. Total inactivation of peptidase activity
was observed with a NBS concentration as low as 10 mM, whereas
6 mM NBS caused over 60% inhibition. The NBS inhibition of
TPPI is also time-dependent, and maximum inhibition with any
concentration of NBS is seen within 5 minutes incubation at 37uC
(data not shown). NBS caused an irreversible-concentration
dependent inhibition of the TPPI at all concentrations tested,
suggesting that the inhibitor covalently modifies amino acid
residue(s) in the enzyme. The TPPI activity was not recovered by
dialyzing out NBS.
Table 1. Concentration-dependent inhibition of bovine brain
TPPI by NBS.






TPPI was preincubated with the freshly prepared NBS solution at the indicated
concentration at 37uC for 5 min. Following preincubation, the tetrapeptide
substrate was added, and TPPI assay performed as described in Experimental
Procedures. Values are represented as mean 6 SD for three independent
measurements.
doi:10.1371/journal.pone.0011929.t001
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While only W residues are modified at lower pH, free sulfhydryl
groups from cysteine residues are preferentially modified at higher
pH [41]. The reaction of sulfhydryl groups with NBS is reversible
with dithiothreitol [42]. In mature human TPPI, there are five
sulfhydryl groups from C residues, four of which are involved in
disulfide bond formation, leaving only one free sulfhydryl group.
There are no known missense mutations involving the free C
residue, according to the NCL mutational database (http://www.
ucl.ac.uk/ncl/), indicating that this residue is not critical for TPPI
catalysis. Because NBS inhibition of TPPI was observed at an
acidic pH of 3.5, and it was irreversible, we reasoned that one or
more of the W rather than the C residues might be oxidized in the
TPPI. Additionally, that would also implicate the significance of W
residues in TPPI catalysis.
Site-directed mutagenesis of TPPI to identify the critical
W residue
In human TPPI, there are altogether 10 W residues; three of
these are removed by autocatalysis in the propeptide, leaving seven
W residues in the mature TPPI. All the W residues in known
mammalian TPPI that are reported in GenBank database are
conserved (data not shown). In order to identify the specific W
residues critical for TPPI catalysis, we have systematically replaced
each of the W residues in human gene sequence with the neutral
amino acid L, and evaluated the enzyme activity of each mutant.
Because the inhibition of TPPI activity was seen with the purified
enzyme, we modified W residues only in the sequence of the
mature enzyme. Mutations were introduced by site-directed
mutagenesis, using synthetic primer pairs encompassing the
mutation site (Table 2). A single g nucleotide in the tgg codon
for W was changed to t nucleotide in the ttg codon for L. The
complete sequence of the TPPI insert in each purified plasmid was
verified by direct dideoxy chain termination DNA sequencing in
both forward and reverse directions with the primers described in
‘‘Experimental Procedures’’ (the partial sequence determined by
DNA sequencing is shown in Figure 1).
TPPI activity in W mutants
To measure the activity of wild-type (wt) and mutant TPPI,
confluent CHO cells were transiently transfected by either circular
wt or each of the L-modified TPPI mutant plasmids. After 48 h, the
cells were collected by brief centrifugation at 8006g, washed once
with normal saline, and then homogenized in 50 mM ammonium
formate buffer, pH 3.5, containing 0.15M NaCl and 0.1% Triton
X-100. After centrifugation, the clear supernatant was stored at
220uC until used for TPPI activity and protein concentration
measurements. Transient transfection of CHO cells by the wt and
mutant TPPI resulted in a 2- to 3-fold higher peptidase activity over
endogenous CHO cells activity (Table 3). The extract from CHO
cells transfected with mutant plasmid W542L had only endogenous
TPPI activity, indicating that this W residue is crucial for enzyme
catalysis. All other CHO cell extracts transfected with other W
mutants had between 2- and 3-fold higher TPPI activities, thereby
suggesting that these W residues are not critical for TPPI activity. A
complete lack of peptidase activity in the W542L mutant confirms
our initial finding of total inhibition of purified bovine TPPI in the
presence of NBS. To rule out the degree of transfection as a possible
factor for the lack of TPPI activity, we also related the TPPI activity
based upon the intensity of the band of mature protein by Western
blot analysis (Figure 2). Again, the mutant W542L showed the
complete loss of TPPI activity and the mature protein.
Table 2. Primer sequences for introducing various W mutants in the TPPI sequence.
Primer Nucleotide Mutation Primer sequence (59 to 39)
CLN2W1F g869t W290L 59-gccaacatctccaccttggtctacagtagcc-39
CLN2W1R g869t_antisense 59-ggctactgtagaccaaggtggagatgttggc-39
CLN2W2F g920t W307L 59-gagcccttcctgcagttgctcatgctgc-39
CLN2W2R g920t_antisense 59-gcagcatgagcaactgcaggaagggctc-39
CLN2W3F g1097t W366L 59-gtggggccgggtgtttgtctgtctctgg-39
CLN2W3R g1097t_antisense 59-ccagagacagacaaacacccggccccac-39
CLN2W4F g1379t W460L 59-ctgcactttctgatggctacttggtggtcagca-39
CLN2W4R g1379t_antisense 59-tgctgaccaccaagtagccatcagaaagtgcag-39
CLN2W5F g1409t W470L 59-caacagagtgcccattccattggtgtccggaac-39
CLN2W5R g1409t_antisense 59-gttccggacaccaatggaatgggcactctgttg-39
CLN2W6F g1625t W542L 59-ctgctctggtcctggcttggatcctgtaaca-39
CLN2W6R g1625t_antisense 59-tgttacaggatccaagccaggaccagagcag-39
CLN2W7F g1643t W548L 59-gggatcctgtaacaggcttgggaacaccc-39
CLN2W7R g1643t_antisense 59-gggtgttcccaagcctgttacaggatccc-39
CLN2W6DF g1625t W542D 59-ctgctctggtcctggcgacgatcctgtaaca-39
CLN2W6DR g1625t_antisense 59-tgttacaggatcgtcgccaggaccagagcag-39
CLN2W6KF g1625t W542K 59-ctgctctggtcctggcaaggatcctgtaaca-39
CLN2W6KR g1625t_antisense 59-tgttacaggatccttgccaggaccagagcag-39
CLN2W6HF g1625t W542H 59-ctgctctggtcctggccacgatcctgtaaca-39
CLN2W6HR g1625t_antisense 59-tgttacaggatcgtggccaggaccagagcag-39
Each of the primer pairs was used to introduce the indicated mutation in the TPPI wt cDNA cloned into the plasmid pcDNA 3.1, by site-directed mutagenesis. The entire
plasmid was amplified by PCR and transfected into competent E.coli cells, and positive colonies were screened by DNA sequencing.
doi:10.1371/journal.pone.0011929.t002
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For the initial essential amino acid residue screening, we have
reduced the electron donor capacity of the side chain at residue 542
by replacing it with a neutral L residue. This resulted in complete
lossofTPPIactivity.Toidentifystructuralrequirementsforposition
542, we have replaced the W with other amino acids using the same
site-directed mutagenesis strategy outlined earlier (Table 2). Three
more mutant plasmids were constructed that possessed either D, H,
or K residues at position 542 (Figure 1). The presence of acidic D
residue or basic H and K residues alsoresulted in the substantial loss
of TPPI peptidase activity. The inhibition, however, was not
complete, and between 18 and 35% of the wt TPPI peptidase
activity was recovered (Table 4), the highest being with the H
mutant. These results suggest that the presence of an electron donor
at position 542 is critical for the peptidase activity of TPPI.
Localization of mutant TPPI
TPPI is a lysosomal peptidase, which is transported by
mannose-6-phosphate receptor–mediated organelle targeting into
lysosomes [43,44]. Critical glycosyl residues are added, TPPI is
folded into its native conformation in the ER, and the final
Figure 1. Site-directed mutagenesis of W residues in TPPI and DNA sequencing. W residues were numbered 1–7 starting from the amino-
terminus. The corresponding amino acid positions in the mature TPPI are 1, W290; 2, W307; 3, W366; 4, W460; 5, W470; 6, W542; and 7, W548. Arrows
indicate the nucleotide change from gRt. Sequence numbers 8–10 are W542D, H, and K mutants, respectively. The bar represents the codon
replaced to change the W residue.
doi:10.1371/journal.pone.0011929.g001
Table 3. TPPI activity in various W mutants.










CHO cells were transiently transfected with various W mutants created by site-
directed mutagenesis. After 48 h, cell pellets were prepared by centrifugation at
8006g for 5 min, rinsed once with normal saline and extracts made in
ammonium formate buffer, pH 3.5, containing 0.15M NaCl and 0.1% triton
X-100. TPPI activity was measured as described in Experimental Procedures.
Values are represented as mean 6 SD for three transfections.
doi:10.1371/journal.pone.0011929.t003
Role of W542 and Ca
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lysosomes. Misfolded proteins that were destined for lysosomes
accumulate in the ER, and these are rapidly degraded by the
cellular quality control machinery [45]. We have evaluated
whether the W mutants are processed completely and transported
to their functional destination, by using confocal microscopy with
organelle specific antibodies (Figure 3 and 4). In transiently
transfected CHO cells, double immunostaining for TPPI and
LAMP, both of which are lysosomal proteins, and calreticulin,
which is a protein that resides in ER, revealed that the W542L
mutant is retained in the ER and is only partially transported out
to the lysosomes, indicating a lack of complete maturation. This
result suggests that W542L mutant may be improperly folded, and
as a result does not leave the ER efficiently. Another mutant,
W542D, was also partially retained in the ER and transported to
the lysosomes indicating a slower processing. While W542L
mutant was completely devoid of enzyme activity, modifying the
W542 residue with other amino acid residues partially recovered
the TPPI activity. The mutant W542D resulted in partial transport
into lysosomes, corroborating the measurement of partial activity.
Mutation of other W residues had no effect on the processing and
targeting into lysosome, as shown by W307L mutant.
Importance of W residues in autocatalysis of pro-TPPI
To further confirm whether the W residues play any critical role
in the autocatalytic maturation of the pro-TPPI, we have studied
the processing of each of the mutants in CHO cells by Western
blot analysis using the 8C4 mouse monoclonal antibody against
TPPI [46]. Immunoblots revealed the presence of W542L and
W542D mutants as pro-TPPI (Figure 5), indicating a lack of
efficient processing to the active enzyme. Two other mutants,
namely, W290L and W307L were also found to have reduced
autocatalysis as indicated by the presence of the majority of
expressed protein as immunoreactive pro-TPPI.
The results obtained by confocal microscopy, Western blot and
biochemical assay suggest that the W542 is critical for maintaining
the proper tertiary structure of the TPPI. Furthermore, these
results also suggest the importance of W542 in the maturation of
the precursor, pro-TPPI, to functionally active TPPI. This creates
a dilemma as to whether the inhibition seen is due to actually W
being modified or due to the protein being misfolded and retained
in ER. Our efforts to create truncated TPPI expressing only the
mature enzyme were unsuccessful, probably due to improper
folding, lack of proper glycosylation or some unknown reason. We
have also made unsuccessful attempts at expressing functionally
active TPPI fused to secretory fragment of yeast.
Importance of Ca
2+ in the autocatalysis of pro-TPPI
Recent X-ray crystallographic data revealed the presence of Ca
2+
in TPPI, the significance of which is currently unclear. An earlier
study from our laboratory showed a lack of inhibition of TPPI by
EDTA [37]. The W542 that was found to be critical for TPPI
activity and pro-TPPI processing is located within the cleft that
binds Ca
2+. To study the importance of Ca
2+ in TPPI, we have
evaluated EDTA and EGTA effects on the processing of pro-TPPI
as well as TPPI activity. Both EDTA and EGTA inhibit the
processing of pro-TPPI in a concentration-dependent manner. For
these studies, pro-TPPI (pH 7.4) was preincubated for 15 min with
Figure 2. Specific activity of TPPI for various W mutants relative to mature TPPI. Freshly plated CHO cells at 70% confluency were
transiently transfected with mutant plasmids using FugeneHD reagent. After 48 h, cells were pelleted by centrifugation at 8006g for 5 min, followed
by homogenization in lysis buffer comprising 50 mM ammonium formate, pH 3.5, containing 0.15M NaCl and 0.1% Triton X-100. TPPI activity was
measured as described in Experimental Procedures and related to the band intensity of mature TPPI by Western blot analysis.
doi:10.1371/journal.pone.0011929.g002
Table 4. Structural requirements for the residue at position
542 for TPPI activity.
Residue at 542 % TPPI activity
W( w t ) 3 0 0
D1 1 8 61
H1 3 5 62
K1 2 9 62
CHO cells were transiently transfected with plasmids comprising various amino
acids at position 542. After 48 h, cell pellets were prepared by centrifugation at
8006g for 5 min and rinsed with normal saline, and extracts were made in
ammonium formate buffer, pH 3.5, containing 0.15M NaCl and 0.1% triton
X-100. TPPI activity was measured as described in Experimental Procedures.
Values are represented as mean 6 SD for three transfections.
doi:10.1371/journal.pone.0011929.t004
Role of W542 and Ca
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autocatalytic processing of pro-TPPI is not active, thus allowing the
Ca
2+ chelating to proceed. Thereafter, the pH was lowered to 3.5,
and incubation continued for an additional 5 min to allow
autocatalysis. At pH 3.5, pro-TPPI is rapidly activated to TPPI,
and the majority of enzyme will be in the active form. Ultimately,
the TPPI activity was measured by the addition of the tetrapeptide
substrate asdescribedin‘‘Experimental Procedures’’. About 50%of
pro-TPPI processing is lost by incubation with 12 mM EDTA
(Table 5 and Figure 6). EDTA was more effective in inhibiting the
autocatalysis of pro-TPPI when compared to an equimolar EGTA
(data not shown). A preincubation with either chelating agent was
found to be necessary to achieve inhibition, which suggests that the
Ca
2+istightlyboundtoTPPI.Incontrast,thepurified TPPIactivity
is not inhibited by either, EDTA or EGTA at concentrations up to
25 mM, in line with our earlier observation. These results suggest
Figure 3. Localization of wt and mutant TPPI in CHO cells. Freshly plated CHO cells at 70% confluency were transiently transfected with
mutant plasmids using FugeneHD reagent. After 24 h, cells were immunostained for TPPI (8C4, monoclonal) and calreticulin (rabbit polyclonal).
Secondary antibodies labeled with Alexa Fluor 488 (green fluorescence visualizing TPPI) and Alexa Fluor 555 (red fluorescence visualizing calreticulin)
were used. Upon merging, the yellow color indicates overlap of expressed proteins. Digital images were taken at a magnification of 61000.
doi:10.1371/journal.pone.0011929.g003
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2+ is important for the proteolytic processing of pro-TPPI
but is not essential for the tripeptidyl peptidase activity.
NBS inhibits autocatalysis of pro-TPPI
NBS is known to break peptide bonds in proteins [47]. We have
evaluated whether the inhibition seen in our studies is the result of
proteolysis. Preincubation of the pro-TPPI with NBS completely
prevented functional autocatalytic activation to TPPI (Figure 6). In
this incubation, the pro-TPPI was processed to a diffuse band with
an apparent ,67-kDa protein. No protein band was observed at
the ,48 kDa area corresponding to the active TPPI, indicating
that NBS also prevents the autocatalytic activation of the
Figure 4. Localization of wt and mutant TPPI in CHO cells. Freshly plated CHO cells at 70% confluency were transiently transfected with
mutant plasmids using FugeneHD reagent. After 24 h, cells were immunostained for TPPI (RAS307, rabbit polyclonal) and LAMP (mouse monoclonal).
Secondary antibodies labeled with Alexa Fluor 488 (green fluorescence visualizing TPPI) and Alexa Fluor 555 (red fluorescence visualizing LAMP) were
used. Upon merging, the yellow color indicates overlap of expressed proteins. Digital images were taken at a magnification of 61000.
doi:10.1371/journal.pone.0011929.g004
Role of W542 and Ca
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pro-TPPI was allowed to undergo in vitro autocatalysis in the
presence of NBS, followed by activity measurement, as described
in ‘‘Experimental Procedures’’ (data not shown). The separation
by SDS-PAGE of pro-TPPI, following incubation with NBS,
EGTA or Ca
2+, failed to reveal any smaller fragments. This
observation suggests that the inhibition of TPPI by NBS is not
through peptide bond breakage.
Discussion
This report identifies a critical residue in the TPPI sequence
that is outside of the active-site triad and is still essential for the
enzyme activity. The results presented have demonstrated that
W542 plays a pivotal role in the catalysis of TPPI. W residues
generally participate in hydrogen bonding through the pyrrole
nitrogen, and thus are critical for maintaining the tertiary structure
in proteins. Although the pyrrole nitrogen is a very weak base, the
hydrogen bonds it forms with other side chain reactive groups
contribute significantly to stabilize structures [48]. By performing
the reaction of NBS with TPPI in formate buffer at acidic pH,
NBS will preferentially oxidize the indole side chain of W residues.
The 2,3 double bond of the pyrrole ring of tryptophan, which is
relative to the carboxamido group of tryptophan residues bound in
peptides, participates in a displacement reaction with NBS
(Figure 7). While NBS has been shown to act in several different
ways to inhibit the activity of protein molecules, including the
breakage of peptide bonds, the present experiments failed to reveal
any smaller species from either TPPI or pro-TPPI upon SDS-
PAGE, suggesting that the inhibition of activity seen is not due to
the breakage of peptide bonds. Thus, the most likely route of NBS
inactivation of TPPI is by oxidation of the indole group of a
specific W residue. Using the site-directed mutagenesis approach
and modifying each of the seven remaining W residues with L, we
have identified W542 to be the most likely residue necessary for
the TPPI activity.
Recent X-ray crystallographic structures of TPPI have shown
presence of octahedrally coordinated Ca
2+ in the structure [32,33].
The function of Ca
2+ was so far unclear. An inspection of the
crystal structure of TPPI reveals that W542 is in a region that is
involved in octahedrally coordinated binding of the Ca
2+. The
residues involved in binding Ca
2+ ions are D517, D543, V518,
G539, and G541. The critical W542 residue is located between
two of these residues G541 and D543, which are involved in this
ionic interaction the former providing the main chain carbonyl
group and the latter through the carboxyl side chain. Our results
have shown that Ca
2+ is critical for autocatalytic cleavage of pro-
TPPI to mature enzyme. This conclusion is deduced from the
inhibition of pro-TPPI processing by two Ca
2+-chelating agents,
EDTA and EGTA. These studies identify the importance of
maintenance of proper tertiary structure around the tight cleft that
binds octahedrally coordinated Ca
2+. Thus, disruption of this
tertiary structure around the Ca
2+-binding area is detrimental
both for the autocatalytic maturation and for the activity of TPPI.
All the Ca
2+ binding residues along with the W542 are conserved
across all mammalian TPPI, indicating their crucial importance in
maintaining the structure.
We have examined the two X-ray crystallographic structures
(3EDY and 3EE6) deposited in the Protein Data Bank using the
software DeepView (http://spdbv.vital-it.ch/). Modeling has
revealed hydrogen bonding between the W542, Y508, D451 and
R447 amino acid residues (Figure 8). These bonds were
determined with a minimum and maximum distance of 1.2–
2.7 A ˚ respectively. The pyrrole nitrogen in W542 is involved in
hydrogen bonding with the hydroxyl group of Y508, which is
involved in hydrogen bonding with the carboxylate side chain of
D451, which in turn is involved in hydrogen bonding with the
guanidinium group of R447 (Figure 8). The NBS reaction with
W542 oxidizes the indole nitrogen, thereby precluding it from
forming hydrogen bonding between this quartet. This reaction
also probably distorts the Ca
2+ binding by D517, V518, G539,
G541 and D543 (Figure 9). Another possibility is that the L
Figure 5. Autocatalytic processing of pro-TPPI. Western blot
analysis of the expression and processing of wt and various mutant TPPI
cDNAs in transiently transfected CHO cells. CHO cells at confluency
were transiently transfected with various plasmids using the FugeneHD
reagent. After 48 h, cells were homogenized in sample buffer, and total
cellular proteins (25 mg) were resolved on 10% SDS-PAGE. After
transferring onto nitrocellulose membrane, TPPI was visualized by
chemiluminesce using mouse monoclonal antibody (8C4). Lane 1, wt
TPPI; lane 2, mutant W290L; lane 3, mutant W307L; lane 4, mutant
W366L; lane 5, mutant W460L; lane 6, mutant W470L; lane 7, mutant
W542L; lane 8, mutant W548L; lane 9, mutant W542D; lane 10, mutant
W542H and lane 11, mutant W542K.
doi:10.1371/journal.pone.0011929.g005
Figure 6. Autocatalytic processing and inhibition of pro-TPPI
by EDTA and NBS. Pro-TPPI was incubated with either 10 mM
Tris.HCl, pH 7.2 (lane 1); 10 mM EDTA, pH 7.2 (lane 2) or 25 mM NBS
(lane 3) in 10 mM Tris.HCl buffer, pH 7.2, at 37uC for 15 min. Thereafter,
the pH was reduced to 3.5 by adding ammonium formate, and
incubation continued for 5 min. The incubation mixtures were resolved
by 10% SDS-PAGE, and proteins were visualized by silver staining.
doi:10.1371/journal.pone.0011929.g006
Table 5. Inhibition of autocatalytic processing of pro-TPPI by
EDTA.






Pro-TPPI was preincubated with indicated EDTA concentration (pH 7.0) for
15 min at 37uC. The reaction mixture was lowered to pH 3.5, and incubation
continued for 5 min at 37uC to allow autocatalysis. TPPI activity was initiated by
adding the tetrapeptide substrate and measuring the product formed as
described in Experimental Procedures.
doi:10.1371/journal.pone.0011929.t005
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2+ binding structure, suggesting
misfolding and resultant entrapment in the ER. Hence, disruption
of the electrophilic nitrogen residue in the W either with NBS or
by site-directed mutagenesis resulted in the complete loss of TPPI
activity, suggesting that the hydrogen bonding in which it is
involved with D451 and Y508 is essential for maintaining the
proper conformation of TPPI. This contention is corroborated by
the fact that replacing W with other amino acid residues that bear
charged side chains instead of neutral L restores partial TPPI
activity. It may not be surprising to find this mutation in
individuals with LINCL involving W542, Y508 or D451. To
date, however, no known mutations have been reported to involve
these residues. These three residues are conserved across all
mammalian TPPI, suggesting that they contribute significantly to
maintaining the proper tertiary structure.
Additionally,theD451residuethatformsahydrogenbondbridge
with Y508 and W542 is localized close to D543, which is involved in
octahedrally binding Ca
2+ ions. Thus, interruption of this hydro-
phobic pocket, either by NBS that is reacting with W542, or by
mutation of R447H, results in the complete loss of TPPI activity. Pal
and colleagues, in the x-ray crystallographic data they obtained with
TPPI, have shown the molecular basis of one of the mutations,
R447H, in an LINCL patient, that results in disruption of a
hydrogen bond at D451 [32]. The residues involved in the Ca
2+
pocket are conserved in the S53 family of serine peptidases,
suggesting a crucial role in catalysis. Our data show that Ca
2+ is
important for the autocatalysis rather than the peptidase activity.
The carboxylate side chain of D451 is involved inhydrogen bonding
with Y508 and R447, of which the Y508 appears to be critical.
An examination of the NCL mutational database for LINCL has
shown only one mutation involving W residues in the TPPI (http://
www.ucl.ac.uk/ncl). This mutation, however, results in a missense
mutation, W460X. Our results with site-directed mutagenesis
revealed that mutation of W460 has no effect on the TPPI activity.
The presence of a nonsense mutation for W460 in an LINCL
patient can be explained by premature termination and a truncated
protein devoid of activity, rather than a direct involvement of this W
mutant in any critical function in the TPPI structure.
The involvement of Ca
2+ in the autocatalytic activation of pro-
TPPI to TPPI is not unique. Studies with maturation of the trans-
Golgi network protease, furin, have shown that autocatalysis of this
protease is Ca
2+-dependent and that it does not occur under
reducing conditions [49]. The precursor pro-furin, in this instance,
is also retained in the ER, similar to what we have observed with
the pro-TPPI mutant W542L. The enzyme prohormone con-
vertase 1 (PC1, or SPC3) is another example that undergoes Ca
2+-
dependent autocatalysis [50]. Both furin and PC1 are examples of
eukaryotic subtilisin-like serine proteinases. Also, in the prokary-
otic subtilisin, the Ca
2+ is involved in stabilizing the protein
structure; however, the enzyme activity is insensitive to chelators
[51]. TPPI is also classified as a subtilisin-like serine proteinase [9].
Whether the active-site triad of TPPI comprising S475-E272-
D360 residues also participates in the autocatalysis is unclear. The
Figure 7. Chemical reaction of NBS with W. NBS reacts with W causing oxidation of the pyrrole part of the indole ring, which results in pyrrole
hydrogen pulled towards the ring more tightly.
doi:10.1371/journal.pone.0011929.g007
Figure 8. Hydrogen bonding between TPPI residues. Interaction
of residues W542, Y508, D451, and R447 through hydrogen bonding. X-
ray crystallographic structure of TPPI, 3EDY, was modeled using the
software DeepView v 4.01 with the hydrogen-bonding function
activated. The hydrogen bridge formed by four amino acids, W542,
Y508, D451, and R447, is shown by the dotted lines without the peptide
backbone.
doi:10.1371/journal.pone.0011929.g008
Role of W542 and Ca
2+ in TPPI
PLoS ONE | www.plosone.org 9 August 2010 | Volume 5 | Issue 8 | e11929involvement ofCa
2+intheprocessing ofthe precursor,butnot inthe
actual peptidase activity, suggests thatinpro-TPPI, different residues
may be involved that cleave off the pro-segment. Additional support
for this contention comes from earlierreports of correct autocatalytic
processingofaS475LmutantfoundinanLINCLpatient[27,52].In
patients exhibiting this mutation, the pro-TPPI is processed to the
48k-Da protein; however, the tripeptidyl peptidase activity is absent,
suggesting that the active-site residues do not participate in the
maturation of TPPI. The function of Ca
2+ in the pro-TPPI could be
two-fold: to stabilize the protein inproper conformation to be able to
deliver to its final destination, the lysosome, and to regulate the
autocatalytic activity. Once in the lysosome, the acidic pH activates
the autocatalyticactivity,therebyreleasingthe active TPPI.Afterthe
pro-enzyme activates, the calcium is no longer essential for the
peptidase activity. However, it may still be stabilizing the structure,
as Ca
2+ is not easily dissociated. Disruption of the tertiary structure
by destroying the hydrogen bonding in the pocket holding the Ca
2+
will result in the loss of TPPI activity.
Of all the inhibitors tested for TPPI, only a substrate-based
derivative of chloromethyl ketone was found to be a potent inhibitor
that caused non-competitive inhibition [53]. Chloromethyl ketone
derivatives inhibit enzymes that have a serine residue as one of the
active-site residues. However, unlike other serine proteinases, the
effectofthis inhibitoronTPPI was foundto be reversible.Theother
inhibitor that had any effect on TPPI activity was DFP, which also
reacts with the active site S475 and inactivates the enzyme. NBS is
the third compound that significantly inhibits the TPPI activity
without affecting the active site. Studies with such compounds will
prove valuable in delineating the critical residues in TPPI catalysis
and its structure-function analysis.
Materials and Methods
Materials
The QuickChange II site-directed mutagenesis kit was procured
from Stratagene, La Jolla, CA. The tetra-peptide substrate GFFL-
aminotrifluoromethyl coumarin (GFFL-AFC) was chemically
synthesized by Enzyme Systems Products, Livermore, CA. A
Qiagen midi kit (Qiagen, Valencia, CA) was used to purify
plasmids from bacterial cultures for transfection experiments. All
other chemicals were purchased from Sigma Chemical Co, St.
Louis, MO. N-Bromosuccinimide (NBS) was recrystallized from
water prior to use.
Methods
Site-directed mutagenesis and transformation of
competent cells. A wild-type (wt) human TPPI cDNA
inserted between the KpnI/NotI sites of pcDNA3.1 Hyro was
used to introduce site-directed mutagenesis. The construction of
the human wt TPPI cDNA has been described earlier [29]. This
cDNA contains the H175R mutation, and additionally has
another polymorphism that retains A348. Each of the seven W
residues in the mature TPPI was altered to L residue according to
the instructions supplied by the manufacturer using the primer
pairs described in Table 2. In this kit, a complete plasmid strand is
first synthesized that incorporates the desired mutation by regular
denaturing, annealing and extension cycles, followed by digestion
of the template strand and transformation of the mutant plasmid
into competent cells.
The mutated plasmids were transformed into HB101 competent
cells (Promega, Madison, WI) as per the manufacturer’s
instructions. Between 4 and 6 colonies were selected, and plasmid
DNA was prepared from each bacterial culture by using the
Wizard Plus plasmid DNA purification kit (Promega, Madison,
WI), following the manufacturer’s suggested protocol.
DNA sequencing. The insertion of WL mutation was verified
by direct sequencing in both the forward and reverse directions.
The following sequencing primers were used: Forward: 769F 59-
CACATCAGGCATCAGTAG-39 and 1206F 59-GGAACCTT-
TCCTCATCAC-39, and reverse: 632R 59-ATCGCTTACGG-
ATCACAG-39 and 1300R 59-GCGCAGGAACTTCGTTAC-39.
Figure 9. Interaction between Ca
2+-binding amino acid residues and hydrogen-bonding quartet involving W542. Interaction of
residues W542, Y508, D451, and R447 through hydrogen bonding along with the Ca
2+ binding residues.
doi:10.1371/journal.pone.0011929.g009
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CEQ 8000 sequencer equipped with capillary electrophoresis
system according to manufacturer’s suggested procedure. Multiple
DNA sequence comparisons were done with publicly available
ClustalW2 software (http://www.ebi.ac.uk/Tools/clustalw2/
index.html) against the NCBI human TPPI mRNA sequence
(locus NM_000391).
CHO cell culture and transient transfection. CHO cells
(ATCC CCL-61) were maintained in F-12 medium supplemented
with 10% fetal calf serum, 2 mM glutamine, and antibiotics
(penicillin and streptomycin) at 37uC in a humidified atmosphere
with 5% CO2. One day before transfection, the CHO cells were
trypsinized, detached and seeded on 35-mm culture dishes. Cells
were transfected by using FuGENE reagent, according to the
manufacturer’s recommendation, with circular plasmids. Forty
eight hours after transfection, cells were trypsinized and collected
by centrifugation at 8006g and rinsed once with normal saline.
TPPI purification. The ,48 kDa mammalian TPPI was
purified to apparent homogeneity from bovine brain as described
earlier [37]. Purified fractions were stored at 220uCi n5 0m M
ammonium formate buffer, pH 3.5, until further use without any
noticeable loss in peptidase activity over extended periods. No
proteolytic fragments were apparent upon SDS-PAGE separation
followed by silver staining.
Pro-TPPI activation. All additions to enzyme preparations
were performed on ice, whereas incubations were conducted at
37uC unless otherwise mentioned. Human pro-TPPI was purified
from serum-free secretions of CHO-DHFR
– cells (ATCC CRL-
9096) stably transfected with plasmid encoding the full-length
human wt TPPI. Vector preparation, cell transfection, selection
and purification procedures were performed essentially as
described previously [29]. Purified pro-TPPI was stored frozen
in 10 mM Tris-HCl, pH 7.4, containing 1 mM EDTA and
0.2 mM PMSF at 220uC indefinitely without measurable loss in
enzyme activity.
At the time of activation, the pro-TPPI was incubated with
25 mM NBS, 10 mM CaCl2 or 10 mM EGTA for 15 min.
Following this preincubation, the pro-TPPI was activated by
autocatalysis in 50 mM ammonium formate buffer, pH 3.5 for
5 min at 37uC, and finally TPPI activity was measured by adding
the substrate GFFL-AFC.
TPPI activity measurement. TPPI enzyme activity was
measured by the sensitive and specific method we developed
earlier with slight modifications [12]. Assays were done in 50 mM
ammonium formate buffer, pH 3.5, for 5 min at 37uC. The
substrate GFFL-AFC, dissolved in 40% dimethylformamide, was
used at a concentration of 180 mM. The reaction was terminated
by adding 100 ml acetonitrile and an aliquot was directly analyzed
by reversed-phase HPLC (HP 1050) on a Microsorb-MV C18
column (4.6 mm610 cm, 3 mm, pore size 100A, Varian Inc, CA).
Eluents were detected by a variable wavelength ultraviolet (UV)
detector at 340 nm, and peaks were integrated by using a HP3395
integrator.
NBS solutions were freshly prepared in distilled water prior to
the experiment. EDTA and EGTA solutions were adjusted to
pH 7.4 by titration with dilute NaOH. When chemicals were
tested for activation or inhibition, they were pre-incubated at 37uC
at the final indicated concentrations with the TPPI for 5–15 min
prior to the addition of the substrate. Thereafter substrate was
added and activity was measured for 5 min at 37uC.
SDS-PAGE and Western Blotting. Samples were solubilized
in the 2X reducing sample buffer, boiled for 5 min, and loaded
onto 10% Tris/HEPES/SDS-polyacrylamide gels (Life Gels).
Electrophoretically separated proteins were stained with silver
nitrate or electrotransferred onto Optitran BA-S83 reinforced
nitrocellulose membrane (Whatman). Nitrocellulose membranes
were blocked with 5% nonfat dry milk in PBST, incubated
overnight with monoclonal antibody 8C4, an anti-TPP I
monoclonal antibody characterized previously [46], then
incubated with horse raddish peroxidase–conjugated secondary
antibodies diluted 1:2,000, and developed by using the
SuperSignal West Pico chemiluminescent substrate (Thermo
Scientific, Rockford, IL). Images were captured either on an X-
ray film or by using a CCD camera attached to a Bioimager (UVP
system, Upland, CA).
To measure autocatalysis, the pro-TPPI was pre-incubated for
15 min at pH 7.4 with NBS, Ca
2+ or EDTA. Following the
preincubation, autocatalysis was initiated by adding ammonium
formate buffer to pH 3.5 and incubating for 5 min. The
incubation mixture was mixed with equal volume of 2X SDS-
PAGE sample buffer and proteins resolved by 10% SDS-PAGE.
After separation, the proteins were fixed using trichloroacetic acid,
and visualized by silver staining.
Immunofluorescence Microscopy. For double
immunostaining, CHO cells grown in LabTek chamber slides
(Nunc Nalage International, Rochester, NY) were fixed with
methanol for 20 min at 4uC. Nonspecific binding sites were
blocked with 10% FCS in PBS for 1 h. After incubation with
primary antibodies diluted in 10% FCS in PBS overnight at 4uC,
cells were washed with PBS and incubated for 1 h at room
temperature with species-specific secondary antibodies conjugated
with fluorescent dyes: Alexa Fluor 488 (for TPP I; green
fluorescence) and Alexa Fluor 555 (for LAMP I and calreticulin;
red fluorescence). The cover slips were mounted with Vectashield
medium and viewed with a Nikon Eclipse E600 laser scanning
confocal microscope. Omission of the primary antibodies was used
as a control of the method.
Protein measurements. Protein concentration in the cell
extracts was determined following the method of Lowry et al [54]
using bovine serum albumin as the standard.
Molecular modeling. Molecular modeling studies were
performed on the x-ray crystallographic structures 1EE6 [32]
and 3EDY [33] accessible at the RCSB protein data bank (http://
www.pdb.org), using the publicly available software DeepView v
4.0 (http://spdbv.vital-it.ch/).
Statistical analyses. Enzyme assays were run in triplicate,
and means 6 SD were determined for each point.
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